Hemispherx Biopharma, Inc. (AMEX: HEB), announced that on May 13, 2014, the United States Patent Office issued U.S. Patent 8,722,874 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE